Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention.


Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
Dec 2022
Historique:
entrez: 8 7 2022
pubmed: 9 7 2022
medline: 12 7 2022
Statut: ppublish

Résumé

To determine the location of coronary atherosclerosis distribution observed in patients with chronic kidney disease (CKD). A cross-sectional study was conducted using the database of cardiovascular medicine data from Saitama Sekishinkai Hospital to clarify the association between renal function and angiographic characteristics of coronary atherosclerosis. In total, 3268 patients who underwent percutaneous coronary intervention were included. Propensity score matching revised the total to 1772. The association of renal function with the location and/or distribution of coronary atherosclerosis lesions was then examined. Overall, coronary lesion was observed in the left anterior descending coronary artery (LAD) in 56% patients, whereas 28% and 22% were in the right coronary artery (RCA) and left circumflex coronary artery (LCX), respectively. LAD was most affected and observed in 57% patients with stage 1 CKD. RCA was second-most affected, at 26% CKD stage 1, but it increased to 31%, 38%, and 59% in CKD 3, 4, and 5, respectively. In CKD 5 patients, the RCA was the most affected artery (59%), with 41% LAD lesions. Logistic regression analysis after propensity score matching showed that the odds ratios for an RCA lesion was 3.658 in CKD 5 ( The prevalence of RCA lesions, but not LAD or LCX lesions, increased with increasing CKD stage. The pathophysiology of coronary atherosclerosis may differ by lesion location. Deterioration of renal function may affect progression of atherosclerosis more in the RCA than in the LAD or LCX.

Identifiants

pubmed: 35801639
doi: 10.1080/0886022X.2022.2093748
pmc: PMC9272943
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1098-1103

Références

N Engl J Med. 2009 Apr 2;360(14):1395-407
pubmed: 19332456
Ther Apher Dial. 2012 Dec;16(6):483-521
pubmed: 23190510
J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838
pubmed: 31582143
Am J Kidney Dis. 2007 Mar;49(3):409-16
pubmed: 17336702
Kidney Int. 2013 Aug;84(2):353-8
pubmed: 23486524
Heart Vessels. 2010 Jan;25(1):14-8
pubmed: 20091393
Kidney Int. 2009 Jan;75(1):80-7
pubmed: 18818684
Circulation. 2003 Oct 28;108(17):2154-69
pubmed: 14581387
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):549-556
pubmed: 30890578
Int Urol Nephrol. 2003;35(2):289-97
pubmed: 15072511
Am J Cardiol. 1969 Dec;24(6):814-25
pubmed: 5360234
Arq Bras Cardiol. 2015 Nov;105(5):493-502
pubmed: 26351983
Nephrol Dial Transplant. 1997 Apr;12(4):718-23
pubmed: 9141000
J Am Coll Cardiol. 2015 Mar 31;65(12):1263-1265
pubmed: 25814235
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Int Heart J. 2014;55(4):301-6
pubmed: 24881584

Auteurs

Naofumi Ikeda (N)

Department of Nephrology, Saitama Sekishinkai Hospital, Sayama, Japan.

Toshihide Hayashi (T)

Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan.

Shikou Gen (S)

Department of Nephrology, Saitama Sekishinkai Hospital, Sayama, Japan.

Nobuhiko Joki (N)

Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan.

Kazuhiko Aramaki (K)

Department of Cardiology, Saitama Sekishinkai Hospital, Sayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH